Article Details

DURECT Co. (NASDAQ:DRRX) Receives Consensus Rating of "Hold" from Analysts

Retrieved on: 2020-08-31 14:14:02

Tags for this article:

Click the tags to see associated articles and topics

DURECT Co. (NASDAQ:DRRX) Receives Consensus Rating of "Hold" from Analysts. View article details on HISWAI:

Excerpt

<div><b>Two Sigma Investments</b> LP now owns 1,008,760 shares of the specialty pharmaceutical company's stock valued at $1,564,000 after acquiring an ...</div>

Article found on:

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up